Ping An Biomedical (PASW) Cash & Equivalents (2024 - 2025)
Ping An Biomedical posted quarterly Cash & Equivalents of $163816.4 for Q3 2025, up 796.76% year-on-year from $18267.7 in Q3 2024, and up 984.16% on a QoQ basis from $15110.0 in Q1 2025.
Ping An Biomedical (PASW) has 2 years of Cash & Equivalents data on file, last reported at $163816.4 in Q3 2025.
- For the quarter ending Q3 2025, Cash & Equivalents rose 796.76% year-over-year to $163816.4; the trailing twelve-month figure through Sep 2025 stood at $163816.4 (up 796.76% YoY), and the FY2025 full-year result was $164697.0, up 801.58% from the prior year.
- Cash & Equivalents for Q3 2025 stood at $163816.4, up from $15110.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $163816.4 in Q3 2025 and bottomed at $15110.0 in Q1 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 163,816.43 |
| Mar 31, 2025 | 15,110.00 |
| Sep 30, 2024 | 18,267.66 |
| Mar 31, 2024 | 82,771.36 |